Laura Y Sue1, Michael Batech, Dhiraj Yadav, Stephen J Pandol, William A Blumentals, Lenore Soodak von Krusenstiern, Wansu Chen, Bechien U Wu. 1. From the *Department of Internal Medicine, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA; †Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA; ‡Division of Gastroenterology, University of Pittsburgh Medical Center, Pittsburgh, PA; §Center for Basic and Translational Pancreatic Research, Cedars-Sinai Medical Center, Los Angeles, CA; ∥Global HEOR and Epidemiology, Shire, Lexington, MA; ¶Clinical Research and Development, Shire, Lexington, MA; and #Center for Pancreatic Care, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA.
Abstract
OBJECTIVES: The aim of this study was to evaluate the effect of serum triglycerides on the development of multiple or persistent organ failure in patients with acute pancreatitis. METHODS: A retrospective cohort study was conducted among patients hospitalized for acute pancreatitis between 2006 and 2013. Triglyceride levels measured before and within 72 hours of admission were compared. In addition, the effect of triglyceride levels on the development of multiple or persistent organ failure during hospitalization for acute pancreatitis was assessed. RESULTS: Among 2519 patients, 267 patients (10.6%) developed organ failure, of which 75 patients developed multiple system organ failure and 82 patients developed persistent organ failure. Triglyceride levels in patients who developed organ failure were initially much higher than in patients who did not develop organ failure, but by 72 hours into admission, approached levels of patients who did not develop organ failure. Approximately 8% of patients had triglyceride levels greater than 500 mg/dL, the majority of which had similarly high levels before admission. CONCLUSIONS: Increased triglyceride levels were associated with the development of multiple or persistent organ failure among patients hospitalized with acute pancreatitis. Patients with high triglyceride levels at the time of admission were likely to have high triglyceride levels before admission.
OBJECTIVES: The aim of this study was to evaluate the effect of serum triglycerides on the development of multiple or persistent organ failure in patients with acute pancreatitis. METHODS: A retrospective cohort study was conducted among patients hospitalized for acute pancreatitis between 2006 and 2013. Triglyceride levels measured before and within 72 hours of admission were compared. In addition, the effect of triglyceride levels on the development of multiple or persistent organ failure during hospitalization for acute pancreatitis was assessed. RESULTS: Among 2519 patients, 267 patients (10.6%) developed organ failure, of which 75 patients developed multiple system organ failure and 82 patients developed persistent organ failure. Triglyceride levels in patients who developed organ failure were initially much higher than in patients who did not develop organ failure, but by 72 hours into admission, approached levels of patients who did not develop organ failure. Approximately 8% of patients had triglyceride levels greater than 500 mg/dL, the majority of which had similarly high levels before admission. CONCLUSIONS: Increased triglyceride levels were associated with the development of multiple or persistent organ failure among patients hospitalized with acute pancreatitis. Patients with high triglyceride levels at the time of admission were likely to have high triglyceride levels before admission.
Authors: Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Frank Sacks; Mohammad Hassan Murad; Anton F H Stalenhoef Journal: J Clin Endocrinol Metab Date: 2012-09 Impact factor: 5.958
Authors: Peter A Banks; Thomas L Bollen; Christos Dervenis; Hein G Gooszen; Colin D Johnson; Michael G Sarr; Gregory G Tsiotos; Santhi Swaroop Vege Journal: Gut Date: 2012-10-25 Impact factor: 23.059
Authors: Y Wang; L Sternfeld; F Yang; J A Rodriguez; C Ross; M R Hayden; F Carriere; G Liu; W Hofer; I Schulz Journal: Gut Date: 2008-10-20 Impact factor: 23.059
Authors: Efstratios Koutroumpakis; Bechien U Wu; Olaf J Bakker; Anwar Dudekula; Vikesh K Singh; Marc G Besselink; Dhiraj Yadav; Rawad Mounzer; Hjalmar C van Santvoort; David C Whitcomb; Hein G Gooszen; Peter A Banks; Georgios I Papachristou Journal: Am J Gastroenterol Date: 2015-11-10 Impact factor: 10.864
Authors: Emese Réka Bálint; Gabriella Fűr; Lóránd Kiss; Dávid István Németh; Alexandra Soós; Péter Hegyi; Zsolt Szakács; Benedek Tinusz; Péter Varjú; Áron Vincze; Bálint Erőss; József Czimmer; Zoltán Szepes; Gábor Varga; Zoltán Rakonczay Journal: Sci Rep Date: 2020-10-21 Impact factor: 4.379